PT952835E - Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae - Google Patents

Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae

Info

Publication number
PT952835E
PT952835E PT97909440T PT97909440T PT952835E PT 952835 E PT952835 E PT 952835E PT 97909440 T PT97909440 T PT 97909440T PT 97909440 T PT97909440 T PT 97909440T PT 952835 E PT952835 E PT 952835E
Authority
PT
Portugal
Prior art keywords
treatment
heart disease
disease caused
chlamidia
pneumoniae
Prior art date
Application number
PT97909440T
Other languages
English (en)
Inventor
Sandeep Gupta
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT952835E publication Critical patent/PT952835E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
PT97909440T 1996-10-18 1997-10-17 Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae PT952835E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2869396P 1996-10-18 1996-10-18
GBGB9621771.6A GB9621771D0 (en) 1996-10-18 1996-10-18 Method of treatment of heart disease
PCT/GB1997/002862 WO1998017280A1 (en) 1996-10-18 1997-10-17 Method of treatment of heart disease caused by chlamydia pneumoniae

Publications (1)

Publication Number Publication Date
PT952835E true PT952835E (pt) 2004-08-31

Family

ID=26310252

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97909440T PT952835E (pt) 1996-10-18 1997-10-17 Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae

Country Status (13)

Country Link
US (1) US6281199B1 (pt)
EP (1) EP0952835B1 (pt)
JP (1) JP3580829B2 (pt)
AT (1) ATE262910T1 (pt)
AU (1) AU736983B2 (pt)
CA (1) CA2269054C (pt)
DE (1) DE69728420T2 (pt)
DK (1) DK0952835T3 (pt)
ES (1) ES2218665T3 (pt)
GB (1) GB9621771D0 (pt)
NZ (1) NZ335825A (pt)
PT (1) PT952835E (pt)
WO (1) WO1998017280A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
FR2791436B1 (fr) * 1999-03-23 2001-06-15 Inst Nat Sante Rech Med Methode de determination d'une predisposition a une maladie tromboembolique veineuse et utilisation d'agents actifs sur les chlamydia pour la prevention et/ou le traitement de cette maladie
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IL133038A0 (en) * 1999-11-18 2001-03-19 Savyon Diagnostics Ltd Novel diagnosis and treatment for atherosclerosis
KR20010069066A (ko) 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
DE60135843D1 (de) * 2000-07-03 2008-10-30 Maria De Lourdes Higuchi Prävention und behandlung von mycoplasma-assoziierten krankheiten mit trans-sialidase und/oder neuraminidase
US7335638B2 (en) * 2000-07-03 2008-02-26 Maria De Lourdes Higuchi Prevention and treatment of mycoplasma-associated diseases
GB2381312B (en) * 2001-08-22 2004-02-18 Cambridge Theranostics Ltd Methods relating to treatment of atherosclerosis
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
WO2003099217A2 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
AU2003281493A1 (en) * 2002-07-18 2004-02-09 Pfizer Products Inc. Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors
EP1575567A4 (en) * 2002-12-12 2008-10-08 Activbiotics Inc METHOD AND REAGENTS FOR TREATING OR PREVENTING ATHEROSCLEROSIS AND DISEASES ASSOCIATED WITH IT
AU2003296963A1 (en) * 2002-12-12 2004-07-09 Activbiotics, Inc. Methods and compositions for treating and preventing ear infections
US7732410B2 (en) * 2003-03-28 2010-06-08 Higuchi Maria De Lourdes Compositions for inhibiting atherosclerosis
US7674832B2 (en) * 2003-03-28 2010-03-09 Higuchi Maria De Lourdes Compositions for promoting wound healing and treating psoriasis
US8822232B2 (en) 2003-03-28 2014-09-02 Maria De Lourdes Higuchi Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
BRPI1004987A2 (pt) 2010-11-26 2013-03-26 Maria De Lourdes Higuchi prevenÇço e tratamento de doenÇas associadas as micoplasma
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
SG11201504842TA (en) * 2012-12-17 2015-07-30 Cormatrix Cardiovascular Inc Intra-myocardial agent delivery device, system and method
US11660269B2 (en) * 2019-03-29 2023-05-30 University Of Kentucky Research Foundation Liposomal compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
EP0192033B1 (en) 1985-01-14 1996-09-25 Chiron Corporation Chlamydia major outer membrane protein
FI883067A (fi) 1988-06-27 1989-12-28 Labsystems Oy Foerfarande foer behandling av koronarkaerlsjukdom.
US5424187A (en) 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma

Also Published As

Publication number Publication date
AU4712697A (en) 1998-05-15
NZ335825A (en) 2001-01-26
JP3580829B2 (ja) 2004-10-27
GB9621771D0 (en) 1996-12-11
EP0952835B1 (en) 2004-03-31
JP2002508738A (ja) 2002-03-19
AU736983B2 (en) 2001-08-09
ES2218665T3 (es) 2004-11-16
ATE262910T1 (de) 2004-04-15
CA2269054C (en) 2005-05-03
WO1998017280A1 (en) 1998-04-30
DK0952835T3 (da) 2004-08-02
CA2269054A1 (en) 1998-04-30
DE69728420D1 (de) 2004-05-06
DE69728420T2 (de) 2004-12-30
US6281199B1 (en) 2001-08-28
EP0952835A1 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
PT952835E (pt) Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae
EA199901016A1 (ru) 9-оксим-производные эритромицина
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
DZ1869A1 (fr) Nouveaux dérivés de lérythromycine, leur procédé de préparation et leur application comme médicaments.
WO2003004509A3 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
SE7703592L (sv) Anthelmintikum
YU41500A (sh) Novi makrolidi
KR890700341A (ko) 저독성 약물-지질계
IL175573A0 (en) Vaccine composition admixed with an alkylphosphatidylcholine
ES515079A0 (es) Un procedimiento para la preparacion de macrolidas c-076
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
NO20016221L (no) Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav
NO934293L (no) Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser
PT1181300E (pt) Derivados 6-o-carbamato de cetolido
OA09447A (fr) Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
YU57900A (sh) Sinteza karbamatno ketolidnih antibiotika
GR3003852T3 (pt)
WO2004000864A3 (en) 11-c-substituted ketolides
MX9803694A (es) Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.
NL1001012A1 (nl) Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling.
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität
FR2707088B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.